Advertisement
Screener

Unity Biotechnology, Inc. Lease, Cost

Unity Biotechnology, Inc. Lease, Cost

Unity Biotechnology, Inc. reported Lease, Cost of $499.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-15.

Discontinued › Operating Expenses

us-gaap:LeaseCost · last filed 2024-04-15

  • Unity Biotechnology, Inc. lease, cost for the quarter ending 2023-12-31 was $67.00K, a 78.86% decline year-over-year.
  • Unity Biotechnology, Inc. lease, cost for the quarter ending 2023-09-30 was $157.00K, a 50.96% increase year-over-year.
  • Unity Biotechnology, Inc. lease, cost for the quarter ending 2023-06-30 was $105.00K, a 79.73% decline year-over-year.
  • Unity Biotechnology, Inc. lease, cost for the quarter ending 2023-03-31 was $170.00K, a 47.85% decline year-over-year.
  • Unity Biotechnology, Inc. lease, cost for fiscal 2023 was $499.00K, a 60.55% decline from fiscal 2022.
  • Unity Biotechnology, Inc. lease, cost for fiscal 2022 was $1.26M, a 62.92% decline from fiscal 2021.
  • Unity Biotechnology, Inc. lease, cost for fiscal 2021 was $3.41M, a 53.25% decline from fiscal 2020.
  • Unity Biotechnology, Inc. lease, cost for fiscal 2020 was $7.30M.
Period endLease, Cost 3 monthLease, Cost 6 monthLease, Cost 9 monthLease, Cost 12 month
2023-12-31$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
$224.00K
derived: sum of 2 quarters · filed 2024-04-15
$329.00K
derived: sum of 3 quarters · filed 2024-04-15
$499.00K
10-K · filed 2024-04-15
2023-09-30$157.00K
10-Q · filed 2023-11-13
$262.00K
derived: sum of 2 quarters · filed 2023-11-13
$432.00K
10-Q · filed 2023-11-13
$749.00K
derived: sum of 4 quarters · filed 2024-04-15
2023-06-30$105.00K
10-Q · filed 2023-08-08
$275.00K
10-Q · filed 2023-08-08
$592.00K
derived: sum of 3 quarters · filed 2024-04-15
$696.00K
derived: sum of 4 quarters · filed 2024-04-15
2023-03-31$170.00K
10-Q · filed 2023-05-09
$487.00K
derived: sum of 2 quarters · filed 2024-04-15
$591.00K
derived: sum of 3 quarters · filed 2024-04-15
$1.11M
derived: sum of 4 quarters · filed 2024-04-15
2022-12-31$317.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
$421.00K
derived: sum of 2 quarters · filed 2024-04-15
$939.00K
derived: sum of 3 quarters · filed 2024-04-15
$1.26M
10-K · filed 2024-04-15
2022-09-30$104.00K
10-Q · filed 2023-11-13
$622.00K
derived: sum of 2 quarters · filed 2023-11-13
$948.00K
10-Q · filed 2023-11-13
$1.36M
derived: sum of 4 quarters · filed 2024-04-15
2022-06-30$518.00K
10-Q · filed 2023-08-08
$844.00K
10-Q · filed 2023-08-08
$1.26M
derived: sum of 3 quarters · filed 2024-04-15
$1.75M
derived: sum of 4 quarters · filed 2024-04-15
2022-03-31$326.00K
10-Q · filed 2023-05-09
$739.00K
derived: sum of 2 quarters · filed 2024-04-15
$1.23M
derived: sum of 3 quarters · filed 2024-04-15
$2.32M
derived: sum of 4 quarters · filed 2024-04-15
2021-12-31$413.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
$907.00K
derived: sum of 2 quarters · filed 2024-04-15
$2.00M
derived: sum of 3 quarters · filed 2024-04-15
$3.41M
10-K · filed 2024-04-15
2021-09-30$494.00K
10-Q · filed 2022-11-08
$1.58M
derived: sum of 2 quarters · filed 2022-11-08
$3.00M
10-Q · filed 2022-11-08
$4.55M
derived: sum of 4 quarters · filed 2023-03-15
2021-06-30$1.09M
10-Q · filed 2022-08-12
$2.50M
10-Q · filed 2022-08-12
$4.06M
derived: sum of 3 quarters · filed 2023-03-15
$5.56M
derived: sum of 4 quarters · filed 2023-03-15
2021-03-31$1.42M
10-Q · filed 2022-05-10
$2.97M
derived: sum of 2 quarters · filed 2023-03-15
$4.47M
derived: sum of 3 quarters · filed 2023-03-15
$5.98M
derived: sum of 4 quarters · filed 2023-03-15
2020-12-31$1.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$3.06M
derived: sum of 2 quarters · filed 2023-03-15
$4.56M
derived: sum of 3 quarters · filed 2023-03-15
$7.30M
10-K · filed 2023-03-15
2020-09-30$1.50M
10-Q · filed 2021-11-10
$3.01M
derived: sum of 2 quarters · filed 2021-11-10
$5.75M
10-Q · filed 2021-11-10
2020-06-30$1.51M
10-Q · filed 2021-08-10
$4.24M
10-Q · filed 2021-08-10
2020-03-31$2.73M
10-Q · filed 2021-05-11